From OT Europe

Registries in orthopaedics and trauma: Don’t miss the main theme in Lisbon

EFORT

Our upcoming EFORT Congress in Lisbon will feature “Registries & Impact On Practice” as the driving motto to highlight key principles around joint arthroplasty and focus on medical device surveillance.

By definition, a medical registry is a voluntary-based collection of information about patients having a specific disorder or having received a treatment in a geographically defined region. The aim of registries, therefore, is to increase the understanding of such a condition or treatment, as well as to allow the design of better studies for development and testing of new therapies. For any orthopaedics and trauma (O&T) practitioner, long-term national arthroplasty registries are an invaluable source of information on the potential risk of failure for a specific implant in comparison to other devices.

NORE, the Network of Orthopaedic Registries of Europe, is an international registry network working to increase awareness of medical device surveillance and arthroplasty outcomes to support improvements in patient care via “the best practices.” Its ultimate purpose is to create a blueprint for emerging registries.

By including three main theme symposia in the 2019 Congress program, the EFORT Science Committee and NORE Standing Committee have built, together with several world-recognized experts, a specific agenda for joint arthroplasty specialists and health care professionals and/or researchers whose practices are directly linked to implant attributes and techniques.

Lisbon Banner

The following information will help one better organize his or her congress experience onsite and identify in advance the main theme sessions to attend:

Wednesday 5 June | 17:00 - 18:30
How and When Registries Make A Difference?

  • Introduction & Moderation: Andreas Loefler (Australia), Rob G. H. H. Nelissen (The Netherlands)
  • Optimising or Too Much Standardising of Clinical Practice Due to Registries? – Dieter Wirtz (Germany)
  • How Can Registry Data Be Used to Drive Genomic Studies? – Mark Wilkinson (United Kingdom)
  • How Can Registry Data Improve Implant Innovation: Lessons Learned – MedTech Europe
  • Joint Registries and Continuous Quality Improvement – Richard De Steiger (Australia)

Friday 7 June | 08:00 - 09:30
Do Surgeons Trust Registry Data?

  • Introduction & Moderation: Rob G. H. H. Nelissen (The Netherlands), Søren Overgaard (Denmark)
  • The Danger of Selection in Registries – Fares Haddad (United Kingdom)
  • Transparency on Hospital Performance Improves – Maziar Mohaddes (Sweden)
  • Who Handles Outliers? – Theofilos Karachalios (Greece)
  • Discontinued and Continued Implants Despite Mediocre Performance – Stephen Graves (Australia)

Friday 7 June | 15:00 - 16:30
NORE Session - Benchmarking Between Patients, Implants and Surgeons

  • Introduction & Moderation: Rob G. H. H. Nelissen (The Netherlands)
  • Patient Profiles in Hip fractures Determine Outcome – Cecilia Rogmark (Sweden)
  • Implant Quality Assessment Improves Outcome (ODEP) – Keith Tucker (United Kingdom)
  • RSA as a Prediction Tool For Good Implants – Rob G. H. H. Nelissen (The Netherlands)
  • Surgeon Comparison Can Improve Outcome in THR and TKR: NJR at 15 Years – Tim Wilton (United Kingdom)

EFORT, as the organization gathering all the national orthopaedic associations in Europe, is a key platform to disseminate education and research on registry data to O&T practitioners, government bodies and related industry.

EFORT is convinced that “Registries & Impact on Practice” can bridge important components within members of the O&T, leading to long-term delivery of better health care and improvement in people’s quality of life.

EFORT

Our upcoming EFORT Congress in Lisbon will feature “Registries & Impact On Practice” as the driving motto to highlight key principles around joint arthroplasty and focus on medical device surveillance.

By definition, a medical registry is a voluntary-based collection of information about patients having a specific disorder or having received a treatment in a geographically defined region. The aim of registries, therefore, is to increase the understanding of such a condition or treatment, as well as to allow the design of better studies for development and testing of new therapies. For any orthopaedics and trauma (O&T) practitioner, long-term national arthroplasty registries are an invaluable source of information on the potential risk of failure for a specific implant in comparison to other devices.

NORE, the Network of Orthopaedic Registries of Europe, is an international registry network working to increase awareness of medical device surveillance and arthroplasty outcomes to support improvements in patient care via “the best practices.” Its ultimate purpose is to create a blueprint for emerging registries.

By including three main theme symposia in the 2019 Congress program, the EFORT Science Committee and NORE Standing Committee have built, together with several world-recognized experts, a specific agenda for joint arthroplasty specialists and health care professionals and/or researchers whose practices are directly linked to implant attributes and techniques.

Lisbon Banner

The following information will help one better organize his or her congress experience onsite and identify in advance the main theme sessions to attend:

Wednesday 5 June | 17:00 - 18:30
How and When Registries Make A Difference?

  • Introduction & Moderation: Andreas Loefler (Australia), Rob G. H. H. Nelissen (The Netherlands)
  • Optimising or Too Much Standardising of Clinical Practice Due to Registries? – Dieter Wirtz (Germany)
  • How Can Registry Data Be Used to Drive Genomic Studies? – Mark Wilkinson (United Kingdom)
  • How Can Registry Data Improve Implant Innovation: Lessons Learned – MedTech Europe
  • Joint Registries and Continuous Quality Improvement – Richard De Steiger (Australia)

Friday 7 June | 08:00 - 09:30
Do Surgeons Trust Registry Data?

  • Introduction & Moderation: Rob G. H. H. Nelissen (The Netherlands), Søren Overgaard (Denmark)
  • The Danger of Selection in Registries – Fares Haddad (United Kingdom)
  • Transparency on Hospital Performance Improves – Maziar Mohaddes (Sweden)
  • Who Handles Outliers? – Theofilos Karachalios (Greece)
  • Discontinued and Continued Implants Despite Mediocre Performance – Stephen Graves (Australia)
PAGE BREAK

Friday 7 June | 15:00 - 16:30
NORE Session - Benchmarking Between Patients, Implants and Surgeons

  • Introduction & Moderation: Rob G. H. H. Nelissen (The Netherlands)
  • Patient Profiles in Hip fractures Determine Outcome – Cecilia Rogmark (Sweden)
  • Implant Quality Assessment Improves Outcome (ODEP) – Keith Tucker (United Kingdom)
  • RSA as a Prediction Tool For Good Implants – Rob G. H. H. Nelissen (The Netherlands)
  • Surgeon Comparison Can Improve Outcome in THR and TKR: NJR at 15 Years – Tim Wilton (United Kingdom)

EFORT, as the organization gathering all the national orthopaedic associations in Europe, is a key platform to disseminate education and research on registry data to O&T practitioners, government bodies and related industry.

EFORT is convinced that “Registries & Impact on Practice” can bridge important components within members of the O&T, leading to long-term delivery of better health care and improvement in people’s quality of life.